Tensions Ratchet In Hanmi Dispute With Offline Wholesalers
This article was originally published in PharmAsia News
South Korea may be one of the most internet-savvy countries where virtually anything can be bought online. But when it comes to e-commerce in the pharmaceutical industry, things are lagging, and growth is being further slowed by strong resistance from the wholesale pharmaceutical distribution industry, as illustrated by a recent dispute.
You may also be interested in...
HanAll and Daewoong remain upbeat on dry eye candidate HL036 and are gearing up for a second Phase III US study despite the first missing its primary endpoint in just-released top-line results.
Among the Korean firms presenting at J.P. Morgan, Hanmi laid out its strategy for obesity and other core pipeline assets, Celltrion focused on its expanding biosimilar pipeline and China plans and LG Chem unveiled new R&D progress.
BeiGene licenses antibody therapeutics for Castleman’s disease and high-risk neuroblastoma.